| 臺大學術典藏 |
2021-07-03T03:33:34Z |
Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions
|
Yu M.-L.;Hung C.-H.;Huang Y.-H.;Peng C.-Y.;Lin C.-Y.;Cheng P.-N.;Chien R.-N.;Hsu S.-J.;Liu C.-H.;Huang C.-F.;Su C.-W.;Huang J.-F.;Liu C.-J.;Kao J.-H.;Chuang W.-L.;Pei-Jer Chen;Chen D.-S.; Yu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; Hsu S.-J.; Liu C.-H.; Huang C.-F.; Su C.-W.; Huang J.-F.; Liu C.-J.; Kao J.-H.; Chuang W.-L.; PEI-JER CHEN; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:33:25Z |
2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population
|
Yu M.-L.; PEI-JER CHEN; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L. |
| 臺大學術典藏 |
2021-07-03T03:33:23Z |
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations
|
Yu M.-L.; PEI-JER CHEN; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L. |
| 臺大學術典藏 |
2021-07-02T03:41:40Z |
Young children with beh?et disease have more intestinal involvement
|
Hung C.-H.; Lee J.-H.; Chen S.-T.; Yang Y.-H.; Lin Y.-T.; Wang L.-C.; Yu H.-H.; BOR-LUEN CHIANG |
| 臺大學術典藏 |
2021-06-04T06:23:14Z |
Carboxylesterase 2 Is a Fatty Acid Ethyl Ester Synthase
|
Tseng Y.-W.; Lin C.-Y.; Tsai C.-L.; Chou T.-Y.; Hung C.-H.; CHING-HUA KUO; Lai S.-C.; Tzeng Y.-J. |
| 臺大學術典藏 |
2021-06-01T07:03:28Z |
Thrombin-induced IL-6 production in human synovial fibroblasts is mediated by PAR1, phospholipase C, protein kinase Cα, c-Src, NF-kappaB and p300 pathway
|
Chiu Y.-C.; Fong Y.-C.; Lai C.-H.; Hung C.-H.; Hsu H.-C.; Lee T.-S.; Yang R.-S.; WEN-MEI FU; Tang C.-H. |
| 臺大學術典藏 |
2021-05-31T02:57:27Z |
Thrombin-induced IL-6 production in human synovial fibroblasts is mediated by PAR1, phospholipase C, protein kinase Cα, c-Src, NF-kappaB and p300 pathway
|
Chiu Y.-C.; Fong Y.-C.; Lai C.-H.; Hung C.-H.; Hsu H.-C.; Lee T.-S.; RONG-SEN YANG; Fu W.-M.; Tang C.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:24Z |
Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions
|
Yu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; Hsu S.-J.; CHEN-HUA LIU; Huang C.-F.; Su C.-W.; Huang J.-F.; Liu C.-J.; Kao J.-H.; Chuang W.-L.; Chen P.-J.; Chen D.-S. |
| 臺大學術典藏 |
2021-05-24T07:20:18Z |
2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population
|
Yu M.-L.; Chen P.-J.; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; CHEN-HUA LIU; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L. |
| 臺大學術典藏 |
2021-05-24T07:20:17Z |
Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
|
Huang C.-F.; Lai H.-C.; Chen C.-Y.; Tseng K.-C.; Kuo H.-T.; Hung C.-H.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; Kao J.-H.; Liu C.-J.; CHEN-HUA LIU; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; Yu M.-L. |
| 臺大學術典藏 |
2021-05-24T07:20:17Z |
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations
|
Yu M.-L.; Chen P.-J.; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; CHEN-HUA LIU; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L. |
| 臺大學術典藏 |
2021-05-24T07:20:16Z |
Successful antiviral therapy reduces risk of schizophrenia among chronic hepatitis c patients: A nationwide real-world Taiwanese cohort (T-COACH)
|
Tsai P.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Kao J.-H.; Liu C.-J.; CHEN-HUA LIU; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Hsieh M.-H.; Huang J.-F.; Dai C.-Y.; Chung W.-L.; Ke C.-L.K.; Yu M.-L.; T-COACH Study Group |
| 臺大學術典藏 |
2021-05-24T07:20:14Z |
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis
|
Hsu W.-F.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; Kao J.-H.; Liu C.-J.; CHEN-HUA LIU; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Tsai P.-C.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y. |
| 臺大學術典藏 |
2021-05-24T07:20:13Z |
Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan
|
Hsieh M.-H.; Bair M.-J.; Tsai P.-C.; Tseng K.-C.; Lo C.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Kao J.-H.; Liu C.-J.; CHEN-HUA LIU; Yan S.-L.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Yu M.-L.; Chuang W.-L.; T-COACH investigators |
| 臺大學術典藏 |
2021-05-24T07:20:12Z |
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan
|
Chen C.-Y.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Lo C.-C.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; CHEN-HUA LIU; Lee M.-H.; Liu C.-J.; Dai C.-Y.; Kao J.-H.; Chuang W.-L.; Lin H.-C.; Yu M.-L. |
| 臺大學術典藏 |
2021-03-04T03:05:24Z |
Authors' response to the Letter to the Editor on “Clinical consideration in evaluating soreness symptoms of fibromyalgia”
|
Chang K.-V.; Hung C.-H.; Sun W.-Z.; Wu W.-T.; Lai C.-L.; DER-SHENG HAN; Chen C.-C. |
| 臺大學術典藏 |
2021-03-04T03:05:22Z |
Evaluating soreness symptoms of fibromyalgia: Establishment and validation of the Revised Fibromyalgia Impact Questionnaire with Integration of Soreness Assessment
|
Chang K.-V.;Hung C.-H.;Sun W.-Z.;Wu W.-T.;Lai C.-L.;Der-Sheng Han;Chen C.-C.; Chang K.-V.; Hung C.-H.; Sun W.-Z.; Wu W.-T.; Lai C.-L.; DER-SHENG HAN; Chen C.-C. |
| 臺大學術典藏 |
2021-01-27T06:52:18Z |
Illusory motion reversal in touch
|
Hsu, Y.-C.;Yeh, C.-I.;Huang, J.-J.;Hung, C.-H.;Hung, C.P.;Pei, Y.-C.; Hsu, Y.-C.; Yeh, C.-I.; Huang, J.-J.; Hung, C.-H.; Hung, C.P.; Pei, Y.-C.; CHUN-I YEH |
| 臺大學術典藏 |
2021-01-27T03:22:18Z |
Illusory motion reversal in touch
|
Hsu, Y.-C.;Yeh, C.-I.;Huang, J.-J.;Hung, C.-H.;Hung, C.P.;Pei, Y.-C.; Hsu, Y.-C.; Yeh, C.-I.; Huang, J.-J.; Hung, C.-H.; Hung, C.P.; Pei, Y.-C.; CHUN-I YEH |
| 臺大學術典藏 |
2021-01-22T04:24:29Z |
Authors' response to the Letter to the Editor on “Clinical consideration in evaluating soreness symptoms of fibromyalgia”
|
Chang K.-V.;Hung C.-H.;Sun W.-Z.;Wei-Ting Wu;Lai C.-L.;Han D.-S.;Chen C.-C.; Chang K.-V.; Hung C.-H.; Sun W.-Z.; WEI-TING WU; Lai C.-L.; Han D.-S.; Chen C.-C. |
| 臺大學術典藏 |
2021-01-22T04:24:27Z |
Evaluating soreness symptoms of fibromyalgia: Establishment and validation of the Revised Fibromyalgia Impact Questionnaire with Integration of Soreness Assessment
|
Chang K.-V.;Hung C.-H.;Sun W.-Z.;Wei-Ting Wu;Lai C.-L.;Han D.-S.;Chen C.-C.; Chang K.-V.; Hung C.-H.; Sun W.-Z.; WEI-TING WU; Lai C.-L.; Han D.-S.; Chen C.-C. |
| 臺大學術典藏 |
2021-01-12T01:17:13Z |
Functional study of diacylglycerol acyltransferase type 2 family in chlamydomonas reinhardtii
|
Ho M.-Y.; Kanehara K.; Hung C.-H.; Hung C.-H.;Ho M.-Y.;Kanehara K.;Nakamura Y.; Nakamura Y.; MING-YANG HO |
| 臺大學術典藏 |
2021-01-06T08:23:36Z |
Young children with beh?et disease have more intestinal involvement
|
Yu H.-H.; Wang L.-C.; Lin Y.-T.; YAO-HSU YANG; Chen S.-T.; Lee J.-H.; Hung C.-H.; Chiang B.-L. |
| 國立成功大學 |
2021 |
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
|
Huang, C.-F.;Kuo, H.-T.;Chang, T.-S.;Lo, C.-C.;Hung, C.-H.;Huang, C.-W.;Chong, L.-W.;Cheng, P.-N.;Yeh, M.-L.;Peng, C.-Y.;Cheng, Cheng C.-Y.;Huang, J.-F.;Bair, M.-J.;Lin, C.-L.;Yang, C.-C.;Wang, S.-J.;Hsieh, T.-Y.;Lee, T.-H.;Lee, P.-L.;Wu, Wu W.-C.;Lin, C.-L.;Su, W.-W.;Yang, S.-S.;Wang, C.-C.;Hu, J.-T.;Mo, L.-R.;Chen, Chen C.-T.;Huang, Y.-H.;Chang, Chang C.-C.;Huang, C.-S.;Chen, G.-Y.;Kao, C.-N.;Tai, C.-M.;Liu, C.-J.;Lee, M.-H.;Tsai, P.-C.;Dai, C.-Y.;Kao, J.-H.;Lin, H.-C.;Chuang, W.-L.;Chen, Chen C.-Y.;Tseng, K.-C.;Yu, M.-L. |
| 國立成功大學 |
2021 |
Combustion performance and emissions from torrefied and water washed biomass using a kg-scale burner
|
Chen, Chen C.-Y.;Chen, W.-H.;Hung, C.-H. |
